Colon polyps differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{SSH}} | {{CMG}}; {{AE}} {{SSH}} | ||
==Overview== | ==Overview== | ||
Colon polyps might present solitary or multiple. Solitary colon polyps usually have no symptoms. Colon polyps must be differentiated from other genetic diseases that cause multiple [[polyps]], such as [[Peutz-Jeghers syndrome]], [[Cowden syndrome]], [[Bannayan–Riley–Ruvalcaba syndrome]], [[juvenile polyposis]], and [[McCune-Albright syndrome]]. | Colon polyps might present solitary or multiple. Solitary colon polyps usually have no symptoms. Colon polyps must be differentiated from other genetic diseases that cause multiple [[polyps]], such as [[Peutz-Jeghers syndrome|Peutz–Jeghers syndrome]], [[Cowden syndrome]], [[Bannayan–Riley–Ruvalcaba syndrome]], [[juvenile polyposis]], and [[McCune-Albright syndrome|McCune–Albright syndrome]]. | ||
==Differentiating Colon Polyps from other Diseases== | ==Differentiating Colon Polyps from other Diseases== | ||
Colon polyps must be differentiated from the following diseases:<ref name="BuckHarned1992">{{cite journal|last1=Buck|first1=J L|last2=Harned|first2=R K|last3=Lichtenstein|first3=J E|last4=Sobin|first4=L H|title=Peutz-Jeghers syndrome.|journal=RadioGraphics|volume=12|issue=2|year=1992|pages=365–378|issn=0271-5333|doi=10.1148/radiographics.12.2.1561426}}</ref><ref>{{cite web |url=https://www.ncbi.nlm.nih.gov/books/NBK1266/#pjs.Diagnosis |title=Peutz-Jeghers Syndrome - GeneReviews® - NCBI Bookshelf |format= |work= |accessdate=}}</ref> | Colon polyps must be differentiated from the following diseases:<ref name="BuckHarned1992">{{cite journal|last1=Buck|first1=J L|last2=Harned|first2=R K|last3=Lichtenstein|first3=J E|last4=Sobin|first4=L H|title=Peutz-Jeghers syndrome.|journal=RadioGraphics|volume=12|issue=2|year=1992|pages=365–378|issn=0271-5333|doi=10.1148/radiographics.12.2.1561426}}</ref><ref>{{cite web |url=https://www.ncbi.nlm.nih.gov/books/NBK1266/#pjs.Diagnosis |title=Peutz-Jeghers Syndrome - GeneReviews® - NCBI Bookshelf |format= |work= |accessdate=}}</ref> | ||
*[[Peutz-Jeghers syndrome]] | *[[Peutz-Jeghers syndrome|Peutz–Jeghers syndrome]] | ||
*[[Cowden syndrome]] | *[[Cowden syndrome]] | ||
* | *Cronkhite–Canada syndrome | ||
*[[Bannayan–Riley–Ruvalcaba syndrome]] | *[[Bannayan–Riley–Ruvalcaba syndrome]] | ||
*[[Juvenile polyposis]] | *[[Juvenile polyposis]] | ||
*[[McCune-Albright syndrome]] | *[[McCune-Albright syndrome|McCune–Albright syndrome]] | ||
Differential diagnosis according to polys: | Differential diagnosis according to polys: | ||
Line 39: | Line 39: | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | – | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | – | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | – | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | – | ||
| style="background: #F5F5F5; padding: 5px;" |SMAD4 | | style="background: #F5F5F5; padding: 5px;" |SMAD4 | ||
[[BMPR1A]] | [[BMPR1A]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | – | ||
| style="background: #F5F5F5; padding: 5px;" |[[Adenoma]]+ | | style="background: #F5F5F5; padding: 5px;" |[[Adenoma]]+ | ||
Line 55: | Line 55: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cowden syndrome|'''Cowden Syndrome''']] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Cowden syndrome|'''Cowden Syndrome''']] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | – | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | – | ||
| style="background: #F5F5F5; padding: 5px;" |[[Axillary]]+ | | style="background: #F5F5F5; padding: 5px;" |[[Axillary]]+ | ||
Line 62: | Line 62: | ||
[[Facial]]+ | [[Facial]]+ | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | – | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | – | ||
| style="background: #F5F5F5; padding: 5px;" |[[Axillary]]+ | | style="background: #F5F5F5; padding: 5px;" |[[Axillary]]+ | ||
Line 69: | Line 69: | ||
[[Facial]]+ | [[Facial]]+ | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | – | ||
| style="background: #F5F5F5; padding: 5px;" |[[PTEN (gene)|PTEN]] | | style="background: #F5F5F5; padding: 5px;" |[[PTEN (gene)|PTEN]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | – | ||
| style="background: #F5F5F5; padding: 5px;" |[[Adenoma]]+ | | style="background: #F5F5F5; padding: 5px;" |[[Adenoma]]+ | ||
Line 79: | Line 79: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Carney syndrome|'''Carney Syndrome''']] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Carney syndrome|'''Carney Syndrome''']] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | – | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | – | ||
| style="background: #F5F5F5; padding: 5px;" |[[Facial]]+ | | style="background: #F5F5F5; padding: 5px;" |[[Facial]]+ | ||
[[Mucous membrane|Mucosal]]+ | [[Mucous membrane|Mucosal]]+ | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | – | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | – | ||
| style="background: #F5F5F5; padding: 5px;" |[[Facial]]+ | | style="background: #F5F5F5; padding: 5px;" |[[Facial]]+ | ||
[[Mucous membrane|Mucosal]]+ | [[Mucous membrane|Mucosal]]+ | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | – | ||
| style="background: #F5F5F5; padding: 5px;" |[[PRKAR1A]] | | style="background: #F5F5F5; padding: 5px;" |[[PRKAR1A]] | ||
| style="background: #F5F5F5; padding: 5px;" | ++ | | style="background: #F5F5F5; padding: 5px;" | ++ | ||
Line 99: | Line 99: | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | – | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | +/ | | style="background: #F5F5F5; padding: 5px;" | +/– | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | – | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |[[APC]] | | style="background: #F5F5F5; padding: 5px;" |[[APC]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | – | ||
| style="background: #F5F5F5; padding: 5px;" |[[Adenoma]]+++ | | style="background: #F5F5F5; padding: 5px;" |[[Adenoma]]+++ | ||
| style="background: #F5F5F5; padding: 5px;" |[[Colon (anatomy)|Colon]], [[brain]] | | style="background: #F5F5F5; padding: 5px;" |[[Colon (anatomy)|Colon]], [[brain]] | ||
| style="background: #F5F5F5; padding: 5px;" |[[Desmoid tumor|Desmoid tumors]], [[Osteoma|osteomas]] | | style="background: #F5F5F5; padding: 5px;" |[[Desmoid tumor|Desmoid tumors]], [[Osteoma|osteomas]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hereditary nonpolyposis colorectal cancer|'''Hereditary | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hereditary nonpolyposis colorectal cancer|'''Hereditary Non–Polyposis Colon Cancer''']] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | – | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | – | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | +/ | | style="background: #F5F5F5; padding: 5px;" | +/– | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | – | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |[[MLH1]] | | style="background: #F5F5F5; padding: 5px;" |[[MLH1]] | ||
Line 129: | Line 129: | ||
[[PMS2]] | [[PMS2]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | – | ||
| style="background: #F5F5F5; padding: 5px;" |[[Adenoma]]+ | | style="background: #F5F5F5; padding: 5px;" |[[Adenoma]]+ | ||
| style="background: #F5F5F5; padding: 5px;" |[[Endometrium|Endometrial]], [[Stomach|gastric]], [[renal pelvis]], [[ureter]], and [[Ovary|ovarian]] | | style="background: #F5F5F5; padding: 5px;" |[[Endometrium|Endometrial]], [[Stomach|gastric]], [[renal pelvis]], [[ureter]], and [[Ovary|ovarian]] | ||
Line 157: | Line 157: | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Weight loss | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Weight loss | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |GI bleeding | ! style="background:#4479BA; color: #FFFFFF;" align="center" |GI bleeding | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" | | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Hypo– | ||
tension | tension | ||
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" | Guarding | ! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" | Guarding | ||
Line 167: | Line 167: | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Colon polyps]] | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Colon polyps]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | – | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | – | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | – | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | – | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | – | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | – | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | – | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | – | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | – | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | – | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | – | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 184: | Line 184: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Peutz-Jeghers syndrome]] | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Peutz-Jeghers syndrome|Peutz–Jeghers syndrome]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Depends on location of polyps it maybe present | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Depends on location of polyps it maybe present | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | – | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | – | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | ||
Line 195: | Line 195: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
* Rectal bleeding may be present due to polyp | * Rectal bleeding may be present due to polyp | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | – | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | – | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | – | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 204: | Line 204: | ||
* STK11 mutation | * STK11 mutation | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
* | * Intra–operative enteroscopy (laparatomy with endoscopy | ||
* Double balloon eneteroscopy | * Double balloon eneteroscopy | ||
* Colonoscopy | * Colonoscopy | ||
Line 221: | Line 221: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | <nowiki>+</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | <nowiki>+</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
* Gastric | * Gastric ulcer– [[melena]] and [[hematemesis]] | ||
* Duodenal | * Duodenal ulcer– [[melena]] and [[hematochezia]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Positive if perforated | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | Positive if perforated | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Positive if perforated | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | Positive if perforated | ||
Line 262: | Line 262: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | ||
Line 316: | Line 316: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Normal or hyperactive | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Normal or hyperactive | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* [[Anti-neutrophil cytoplasmic antibody]] ([[P-ANCA]]) in [[Ulcerative colitis]] | * [[Anti-neutrophil cytoplasmic antibody|Anti–neutrophil cytoplasmic antibody]] ([[P-ANCA|P–ANCA]]) in [[Ulcerative colitis]] | ||
* [[Anti saccharomyces cerevisiae antibodies]] (ASCA) in [[Crohn's disease]] | * [[Anti saccharomyces cerevisiae antibodies]] (ASCA) in [[Crohn's disease]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* [[String sign]] on [[abdominal x-ray]] in [[Crohn's disease]] | * [[String sign]] on [[abdominal x-ray|abdominal x–ray]] in [[Crohn's disease]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Extra intestinal findings: | Extra intestinal findings: | ||
Line 374: | Line 374: | ||
* PILLCAM 2: A colon capsule for CRC screening may be used in patients with an incomplete colonoscopy who lacks obstruction | * PILLCAM 2: A colon capsule for CRC screening may be used in patients with an incomplete colonoscopy who lacks obstruction | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Budd-Chiari syndrome| | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Budd-Chiari syndrome|Budd–Chiari syndrome]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[RUQ]] | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[RUQ]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | ||
Line 394: | Line 394: | ||
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | {| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Findings on [[CT scan]] suggestive of | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Findings on [[CT scan]] suggestive of Budd–Chiari syndrome include: | ||
*Early enhancement of the [[caudate lobe]] and [[central liver]] around the [[Inferior vena cavae|inferior vena cava]] | *Early enhancement of the [[caudate lobe]] and [[central liver]] around the [[Inferior vena cavae|inferior vena cava]] | ||
*Delayed enhancement of the peripheral [[liver]] with accompanying central low density ( | *Delayed enhancement of the peripheral [[liver]] with accompanying central low density (flip–flop appearance) | ||
*Peripheral zones of the [[liver]] show reversed [[portal]] [[venous]] [[blood flow]] | *Peripheral zones of the [[liver]] show reversed [[portal]] [[venous]] [[blood flow]] | ||
*In the [[chronic]] phase, there is [[caudate lobe]] enlargement and [[atrophy]] of the [[Liver|peripheral liver]] in affected areas | *In the [[chronic]] phase, there is [[caudate lobe]] enlargement and [[atrophy]] of the [[Liver|peripheral liver]] in affected areas | ||
Line 461: | Line 461: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Stigmata of liver disease | * Stigmata of liver disease | ||
* | * Cruveilhier– Baumgarten murmur | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Mesenteric ischemia]] | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Mesenteric ischemia]] | ||
Line 480: | Line 480: | ||
* [[Leukocytosis]] and [[lactic acidosis]] | * [[Leukocytosis]] and [[lactic acidosis]] | ||
* [[Amylase]] levels | * [[Amylase]] levels | ||
* [[D-dimer]] | * [[D-dimer|D–dimer]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |CT angiography | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |CT angiography | ||
* SMA or SMV thrombosis | * SMA or SMV thrombosis | ||
Line 502: | Line 502: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* [[Leukocytosis]] | * [[Leukocytosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Abdominal x-ray]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Abdominal x-ray|Abdominal x–ray]] | ||
* Distension and pneumatosis | * Distension and pneumatosis | ||
CT scan | CT scan | ||
Line 526: | Line 526: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* [[Fibrinogen]] | * [[Fibrinogen]] | ||
* [[D-dimer]] | * [[D-dimer|D–dimer]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Focused Assessment with Sonography in Trauma (FAST) | * Focused Assessment with Sonography in Trauma (FAST) | ||
Line 532: | Line 532: | ||
* Unstable hemodynamics | * Unstable hemodynamics | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" | | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |Intra–abdominal or [[retroperitoneal hemorrhage]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Diffuse | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | Diffuse | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± |
Revision as of 11:12, 22 January 2018
Colon polyps Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Colon polyps differential diagnosis On the Web |
American Roentgen Ray Society Images of Colon polyps differential diagnosis |
Risk calculators and risk factors for Colon polyps differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Overview
Colon polyps might present solitary or multiple. Solitary colon polyps usually have no symptoms. Colon polyps must be differentiated from other genetic diseases that cause multiple polyps, such as Peutz–Jeghers syndrome, Cowden syndrome, Bannayan–Riley–Ruvalcaba syndrome, juvenile polyposis, and McCune–Albright syndrome.
Differentiating Colon Polyps from other Diseases
Colon polyps must be differentiated from the following diseases:[1][2]
- Peutz–Jeghers syndrome
- Cowden syndrome
- Cronkhite–Canada syndrome
- Bannayan–Riley–Ruvalcaba syndrome
- Juvenile polyposis
- McCune–Albright syndrome
Differential diagnosis according to polys:
Diseases | History and Symptoms | Physical Examination | Laboratory Findings | Other Findings | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Abdominal Pain | Rectal Bleeding | Hyperpigmentation | Fatigue | Abdominal Tenderness | Hyperpigmentation | Anemia | Gene(s) | Sertoli Cell Tumors | Gastrointestinal Tumors | Cancers | ||
Juvenile Polyposis Syndrome | + | – | + | – | – | – | SMAD4 | – | Adenoma+
Hamartoma+++ |
Colon | ||
Cowden Syndrome | – | – | Axillary+ | – | – | Axillary+ | – | PTEN | – | Adenoma+
Hamartoma+++ |
Breast, Thyroid, Endometrium | Trichilemmoma, skin hamartoma, hyperplastic polyps, macrocephaly, breast fibrosis |
Carney Syndrome | – | – | Facial+ | – | – | Facial+ | – | PRKAR1A | ++ | Thyroid | Myxomas of skin and heart | |
Familial Adenomatous Polyposis | + | + | – | + | +/– | – | + | APC | – | Adenoma+++ | Colon, brain | Desmoid tumors, osteomas |
Hereditary Non–Polyposis Colon Cancer | – | + | – | + | +/– | – | + | MLH1 | – | Adenoma+ | Endometrial, gastric, renal pelvis, ureter, and ovarian | Sebaceous adenoma |
|
References
- ↑ Buck, J L; Harned, R K; Lichtenstein, J E; Sobin, L H (1992). "Peutz-Jeghers syndrome". RadioGraphics. 12 (2): 365–378. doi:10.1148/radiographics.12.2.1561426. ISSN 0271-5333.
- ↑ "Peutz-Jeghers Syndrome - GeneReviews® - NCBI Bookshelf".